Pretreatment of a Dacron graft with tissue factor pathway inhibitor decreases thrombogenicity and neointimal thickness: A preliminary animal study

ASAIO Journal

Volumn 47, Issue 4, 2001, Pages 325-328

  Sun, Ling Bo ^a   Utoh, Junichi ^a   Moriyama, Shuji ^a   Tagami, Hirofumi ^a   Okamoto, Ken ^a   Kitamura, Nobuo ^a  

^a KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PLANIMETERS; SCANNING ELECTRON MICROSCOPY; TISSUE;

ALBUMIN COATED KNITTED DACRON GRAFTS; THROMBOGENICITY;

IMPLANTS (SURGICAL);

HEPARIN; TISSUE FACTOR PATHWAY INHIBITOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA; ARTERY INTIMA PROLIFERATION; ARTICLE; CONTROLLED STUDY; DACRON IMPLANT; DOG; ENDOTHELIUM CELL; GRAFT PATENCY; INTIMA; NONHUMAN; SCANNING ELECTRON MICROSCOPY; THROMBOGENICITY; THROMBUS;

EID: 0034940629     PISSN: 10582916     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002480-200107000-00005     Document Type: Article

References (24)

1. Comparative evaluation of prosthetic, reversed, and in situ vein bypass grafts in distal popliteal and tibial-peroneal revascularization
2. Infrapopliteal bypass for severe ischemia: Comparison of autogenous vein, composite, and prosthetic grafts
3. Small-diameter vascular graft prostheses: Current status
4. Tissue factor pathway inhibitor: From unknown coagulation inhibitor to major antithrombotic principle
5. Local irrigation with tissue factor pathway inhibitor inhibits intimal hyperplasia induced by arterial interventions
6. Prevention of microvascular thrombosis by topical application of recombinant tissue factor pathway inhibitor
7. Topically applied: Tissue factor pathway inhibitor reduced intimal hyperplasia in a rabbit model of small arterial autografts
8. Pharmacologic intervention to prevent graft failure
9. Covalent linkage of recombinant hirudin to poly (ethylene terephthalate) (Dacron): Creation of a novel antithrombin surface
10. Heparin bonding increases patency of long microvascular prostheses
11. Small diameter vascular prostheses with incorporated bioabsorbable matrices. A preliminary study
12. Improvement of patency rate in heparin-coated small synthetic vascular grafts
13. Can heparin immobilized surfaces maintain nonthrombogenic activity during in vivo long-term implantation?
14. Thrombogenicity of small-diameter prosthetic grafts: Relative contributions of graft-associated thrombin and factor Xa
15. Efficacy of local inhibition of procoagulant activity associated with small-diameter prosthetic vascular grafts
16. Small caliber vascular grafts: I. State of the art
17. Thrombin immobilized to extracellular matrix is a potent mitogen for vascular smooth muscle cells: Nonenzymatic mode of action
18. Structural requirements for TFPI-mediated inhibition of neointimal thickening after balloon injury in the rat
19. Direct in vivo observations of embolic events in the microcirculation distal to a small-vessel anastomosis
20. Thrombus formation and endothelial alterations in microarterial anastomoses
21. Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III- independent inhibitors
22. Does increased diameter of vascular prostheses really enhance patency rates?
23. Femoropopliteal reconstruction with knitted, nonvelour Dacron versus expanded polytetrafluoroethylene
24. Prosthetic above-knee femoropopliteal bypass grafting: Results of a multicenter randomized prospective trial